Recall
FDAHealthJune 5, 2026

Inventia Healthcare Limited — Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (Eas

⚠️ Failed Dissolution Specifications

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
June 5, 2026

U.S. Nationwide.

What's affected?

Product
Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10
UPC
0364980599108
Lot code
[100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027

Additional details

[100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 11,460 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.